SynthesisPathogens and global health2025
Prevalence of oral human papillomavirus infection in African countries: a systematic review and meta-analysis.
Synthesis in Pathogens and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Knowledge and attitudes of dental clinic attendees on oral HPV infection in Ibadan, Nigeria.BMC oral health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This meta-analysis aimed to provide pooled overall prevalence estimates of oral human papillomavirus (HPV) infection in Africa. A literature search for cross-sectional studies was conducted until January 2025. The Newcastle-Ottawa Scale assessed the methodological quality. Random-effects model estimated the pooled prevalence of oral HPV infection. Sub-group analyses were conducted using study characteristics as covariates. Thirty-three studies involving 4.607 participants from 9 countries were included. Prevalence of oral HPV infection ranged between 0% to 95.1%, with a pooled overall estimate of 15.8%. The studies exhibited considerable heterogeneity (I2 = 99.3%). Subgroup analyses revealed the highest prevalence among participants with head and neck cancer (19.9%), from sub-Saharan area (19.2%), female (17.3%), moderate-low-quality studies (16.7%), and in HIV-positive (5.8%). High-quality studies with an accurate collection of the risk factors are needed for tailoring programs and health-care policies to prevent and control oral HPV infection and associated diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.